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ABSTRACT
Background: Angioedema with eosinophilia (AE) is mostly reported in Japanese patients, and only as case
reports. In this study, we aimed to determine how prevalent AE cases appear, the characteristic features and
the course of AE, and to evaluate whether corticosteroid therapy for AE is necessary or not.
Methods: The patients whose blood samples showed an eosinophil count of 2,000μL, among the samples
tested for blood cell counts and differential counts between January 2006 and December 2010, in Japanese
Red Cross Medical Center, were firstly included. Among these, patients with AE were extracted.
Results: All of the 11 patients were Japanese young females. One patient with arthralgia showed radioisotope
accumulation in the joints by bone scintigraphy. The peak peripheral blood eosinophil count was 7,839 ± 6,008
(2,130-23,170)μL after visiting our hospital. An increase in white blood cell count was only due to an increase
in eosinophil count. Serum C-reactive protein and IgE levels remained almost normal. Peripheral blood eosino-
phil count decreased steadily for 8 weeks, regardless of corticosteroid use. Edema in all of the patients and ar-
thralgia in 6 patients improved within 12 weeks. As far as followed, none of the patients had a recurrence of AE.
Conclusions: AE developed in Japanese young females and likely showed a single course. In AE, the count
of eosinophil of 104μL was observed. Only eosinophil count increased among leukocyte series. Serum C-
reactive protein and IgE levels remained almost normal. The eosinophil count in AE patients will return to the
normal level within 8 weeks even without corticosteroid therapy.
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INTRODUCTION
Episodic angioedema with eosinophilia (EAE) was
first reported in 1984 by Gleich et al..1 This was char-
acterized by peripheral blood eosinophilia, elevated
serum IgM level, fever, urticaria, weight gain, angioe-
dema, and absence of involvement of internal organs.
After that, several case reports of angioedema with
eosinophilia (AE) were published.2-12
In 1998, Chikama et al. reported the cases of tran-
sient variant EAE in Japan, which was proposed as
nonepisodic angioedema with eosinophilia (NEAE).13
Almost all the reported AE cases in Japan and Korea
were nonepisodic.14-19 These NEAE cases involved
mostly young females, whose features were edema
localized in the hands and feet, arthralgia, eosino-
philia, normal immunoglobulin levels, and lack of in-
ternal organ involvement.14-19 Some of the NEAE
cases remitted spontaneously within a few months
and had only a single attack. However, despite the
possibility of spontaneous remission, lack of informa-
tion about the clinical characteristics and the course
of AE sometimes results in the tendency to adminis-
ter corticosteroid owing to a surprisingly high periph-
eral blood eosinophil count and marked symptoms.
No report has been available on a larger number of
AE cases more than 10 in a single hospital. There has
also been no report showing the prevalence of AE, or
clearly showing no need for corticosteroids, so far.
We have treated 11 AE patients in our hospital. Thus,
we retrospectively evaluated our patients with AE to
determine how prevalently it appeared, characteris-
tics, and clinical courses of AE including the thera-
pies for AE and their outcomes and to determine
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Table　1　Clinical and laboratory features of angiodema with eosiophilia patients
Patient Age/sex
Cilnical symptoms Laboratory data
Steroid 
therapyFever
Weight 
gain 
(kg)
Arthral-
gia
Dura-
tion of 
symp-
toms 
(weeks)
WBCs 
(/μL)
Eosino-
phil
 (/μL)
Neutro-
phil
(/μL)
IgG
 (g/L)
IgA
 (g/L)
IgM 
(g/L)
IgE 
(IU/mL)
CRP 
(mg/L)
ESR 
(mm/
h)
 1 24/F - NA -  2 29,100 23,170 2,840 10.77 1.28 1.97  48  1.1 ND -
 2 24/F - NA +  3 22,500 14,440 5,010 10.72 3.22 0.70  49  0.8 7 -
 3 28/F - NA +  4 14,400 9,430 2,980 9.50 1.27 1.57  97  0.5 4 -
 4 37/F - 5 +  4 15,300 8,640 4,310 14.28 1.46 1.84  81  1.0 8 -
 5 28/F - NA -  2 15,200 8,170 3,760 13.68 1.66 1.63 359  0.3 ND -
 6 34/F - NA +  8 14,800 6,900 6,130 13.69 1.62 0.75 189  0.8 ND +†
 7 38/F - 1 + 12 9,200 3,700 2,960 9.53 1.12 1.93  46  0.3 2 +†
 8 24/F - NA -  5 11,800 3,520 6,040 10.91 1.53 2.05  21  0.1 ND -
 9 29/F - NA -  6 10,200 3,470 4,230 11.68 2.20 ND ND  0.4 ND -
10 23/F - 1 +  4 9,100 2,660 4,460 9.90 1.32 1.08  18 23.4 7 -
11 24/F - NA -  8 12,500 2,130 8,550 ND ND ND ND  0.3 ND +‡
NA, Not available; ND, Not determined; F, female; WBCs, White blood cells; CRP, C-reactive protein; ESR, Erythrocyte sedimantation 
rate.
†Transient use.
‡Continued use.
whether corticosteroid treatment of AE is necessary
or not.
METHODS
The patients, who visited Japanese Red Cross Medi-
cal Center, and whose blood samples were measured
for blood cell counts and differential counts, and
showed an eosinophil count of 2,000μL, between
January 2006 and December 2010, were firstly in-
cluded. Among these, patients with AE were ex-
tracted. AE was diagnosed by doctors in charge,
mainly on the basis of angioedema on distal extremi-
ties that developed concurrently with peripheral
eosinophilia and improved in parallel with a decrease
in eosinophil count. The patients’ medical charts
were reviewed for sex, age, past history of any aller-
gies, and any episodes of something as such infection
before the development of edema. Fever, body
weight gain, symptoms other than edema including
arthralgia or arthritis, and internal organ involvement
were also examined. The durations of symptoms and
eosinophilia, corticosteroid dose, and treatment out-
comes were also checked. The clinical charts were
reviewed until their last visits. Laboratory test pa-
rameters examined included white blood cell (WBC),
eosinophil, and WBC other than eosinophil counts,
serum IgG, IgA, IgM, and IgE levels, C-reactive pro-
tein (CRP) level, and erythrocyte sedimentation rate
(ESR). A whole body bone scintigraphy with 99mTc
methylene diphosphonate was performed to evaluate
arthritis. Exclusion criteria were preexisting underly-
ing diseases other than allergies, pre-use of corti-
costeroid for diseases other than AE. Whether the pa-
tients had a recurrence of AE or not, afterwards, was
studied by means of making calls to them. As this
study was retrospective chart-oriented study, in-
formed consent was taken from all of the patients we
could reach. The study design was approved by the
ethical committee of our hospital.
RESULTS
During the study period, 474,538 blood samples over
the age of 20 were examined for the differential count
of WBCs. Among them, 600 samples from 223 pa-
tients showed an eosinophil count of 2,000μL.
Eleven patients out of the 223 were diagnosed as hav-
ing AE.
All of them were Japanese females, aged 28.5 ± 5.3
(range: 23-38). The duration of edema was 5.2 ± 2.8
(range: 2-12) weeks. The follow-up period was 5.8-7.0
(range: 1-23) months. 8 out of 11 patients could have
had a contact by phone; all of them had no recur-
rence of AE after their last visit to date, for 19.9 ± 15.0
(range: 1-49) months.
Clinical symptoms and laboratory data are listed in
Table 1. None of the patients had any other preexist-
ing or concurrently developing underlying disease in-
cluding infectious diseases, malignancies, and colla-
gen diseases other than allergies. One patient had
atopic dermatitis, and another had aspirin allergy. No
internal organ involvement was observed in any pa-
tients. An increase in body weight of up to 5 kg was
documented in four patients. Edema was observed in
distal extremities symmetrically, mostly in the hands
and feet, and severe around the joints. As for the ar-
ticular symptom, 6 patients had it symmetrically in
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Fig.　1　Peripheral blood WBC and eosinophil counts in AE patients. Patients 6 and 7 were 
transiently administered a low dose of a corticosteroid. Patient 11 had had tapering dose of a 
corticosteroid.
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several joints; 2 of them underwent bone scintigra-
phy. One of them showed active radioisotope accu-
mulation in the joints. The other patient, who already
showed improvement of the articular symptom when
tested, showed no radioisotope accumulation.
The peak peripheral blood eosinophil count in our
hospital was 7,839 ± 6,008 (2,130-23,170)μL. The se-
rum IgE (101 ± 104 IUmL), IgG (11.47 ± 1.71 gL),
IgA (1.67 ± 0.59 gL), and IgM (1.50 ± 0.50 gL) lev-
els were normal. Serum CRP level was within normal
limits with the exception of one patient who had ar-
thritis with active radioisotope accumulation. Serum
lactate dehydrogenase (LDH) level slightly increased
(266 ± 36 IUL, normal range: 118-240 IUL).
An increase in WBC count was only due to an in-
crease in eosinophil count (Fig. 1), that is, the count
of leukocytes except for eosinophils including neutro-
phils, basophils, monocytes, and lymphocytes, did
not change throughout the course of eosinophil in-
crease and decrease in each patient except for Patient
11. Patient 11 was administered a sustained corti-
costeroid, who showed a decreasing eosinophil count
and an increased neutrophil count, which are indica-
tive of corticosteroid use.
The courses of decrease in peripheral blood
eosinophil counts are shown in Figure 2. Peripheral
blood eosinophil count decreased steadily for 6
weeks after the first visit.
Regarding prednisolone therapy, Patient 6 had only
3 mgday for 3 days, Patient 7 had 5 mgday for 10
days, and Patient 11 had 20 mgday for 4 days which
was tapered to 0 mg in 16 days, before visiting our
hospital. None of the patients had additional corti-
costeroids in our hospital. Anthelmintic was not ad-
ministered to any patients. Edema in all of the pa-
tients and arthralgia in 6 patients improved within 2
months; the most rapid improvement was observed
in 2 weeks. As shown in Figure 2b, the declining
courses of eosinophil count did not differ between pa-
tients with or without corticosteroid. The lineal de-
clining manner in logarithmic scale sustained for up
to 6 weeks. The changing courses in patients with
corticosteroid were similar to those in 8 patients with-
out it. Although the changing course in another pa-
tient was not available, the symptom courses of these
3 patients did not differ especially from other pa-
tients.
DISCUSSION
As far as we searched the English literature, almost
all clinical reports on AE were case reports and no
study including 10 cases in a single hospital has
been reported. The prevalence of AE has not yet
been determined. Although many of the reported
cases required no corticosteroid treatment, the time
course of eosinophil count was not described.
We tried to elucidate how prevalent AE were ap-
peared in our hospital. 0.1% of the total samples
tested showed eosinophil count of2,000μL. Among
all of the 223 patients with an eosinophil count of 
2,000μL, 11 (4.9%) had AE. Among eosinophilia pa-
tients with a count of 5,000μL, 641 (14.6%) had
AE, and among those with a count of 10,000μL, 2
18 (11.1%) had AE. This indicates that AE is actually a
relatively common disease among patients with
eosinophilia, particularly among patients with a much
higher count. We have treated more than 10 AE pa-
tients during 3 years in our ordinary general hospital
with specialists in allergology. It appears that if AE is
widely known, much more cases of AE would be de-
tected at least in Japan.
The mean eosinophil count in AE patients was as
high as 7,839μL, and 2 patients showed a maximum
count of 10,000μL. This indicates that the eosino-
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Fig.　2　Changes in peripheral blood eosinophil count. Patients 6, 7, and 11 shown as dotline 
had corticosteroid treatment before visiting our hospital. (a) In real number. (b) In logarithmic 
number.
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phil count in AE patients is comparatively higher than
that in other diseases with eosinophilia such as atopic
diseases, in which the count is usually only mildly in-
creased. Despite such a high eosinophil count, AE
has no serious internal organ involvement. Regarding
serum IgE level, all of our patients except one
showed levels within the normal range, and none of
the patients showed a markedly high level. Concern-
ing inflammatory markers, CRP level did not increase
except for one patient who had arthritis, and ESR was
not elevated in all of the patients. Serum IgM level
was within normal range in our patients, although a
high level was reported by Gleich et al. as a charac-
teristic feature of EAE.1
All of the AE patients in our hospital were Japanese
young women, had edema localized in distal extremi-
ties, and had a slight weight gain; these features were
quite similar to those in many case reports from Ja-
pan.3-18 Although arthritis complicated by AE was de-
scribed in many reports,6,14,16-19 no confirmed diagno-
sis was made. We conducted bone scintigraphy on 2
patients, and observed radioisotope accumulation in
the joints in one in the active phase of arthralgia that
developed concurrently with eosinophilia. In another
patient, a scarce accumulation was observed when
examined after arthralgia subsided with a decreased
eosinophil count. A bone scintigraphy image showed
that arthritis could have actually taken place at least
in some patient in the active phase of AE.
Not only the pathogenesis, but preexisting status
of AE has been so far unclear. One case of AE after
an infection was reported.20 However, our patients
did not have any preexisting status or preceding
events such as an allergic attack or an infection.
None of our patients have revisited our hospital af-
ter their follow-up period and there has been no re-
quest for patients’ information from other hospitals
concerning the recurrence of AE in these patients to
date. AE did not recur in all of our patients during the
follow-up period of 3 to 30 months. This observation
is consistent with that in many reports, i.e., AE in
Japanese patients is generally nonepisodic.13-18 Jang
Angioedema with Eosinophilia in Japan
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et al. reported that AE in Korean patients was also
nonepisodic and involved young women.19 Although
it is difficult to confirm whether AE is nonepisodic or
episodic, most cases of AE in Japanese and also Ko-
rean patients are considered to be nonepisodic, at
least as far as the reports’ follow-up periods cov-
ered.13-19
A corticosteroid is sometimes administered to pa-
tients with AE more likely owing to a substantial ele-
vation of peripheral blood eosinophil count, rather
than owing to patients’ complaints or the physical
finding of edema. However, most AE patients might
have attained a complete remission without corti-
costeroid treatment, as was obtained in most of our
patients, with and without corticosteroid treatment.
The decrease in eosinophil count tended to be linear
in a logarithmic scale, and almost the same with or
without corticosteroid treatment.
In a case in which the AE patient is a young Japa-
nese female, presents with angioedema in the distal
extremities, shows an increased peripheral blood
eosinophil count, and shows neither serum IgE level
elevation nor positive inflammatory markers, corti-
costeroids should not be administered to such a pa-
tient. Edema and other symptoms will disappear in
several weeks. Among diseases complicated by
eosinophilia, AE is rather much more prevalent, par-
ticularly among cases with an eosinophil count of 
5,000μL.
When predicting the course of decrease in eosino-
phil count, the count might return to the normal level
within eight weeks, as supposed from the logarithmic
graph in Figure 2b.
In conclusion, AE developed in Japanese females,
and likely showed a single course. In AE, an eosino-
phil count of 104μL was observed. Only eosinophil
count increased without an increase in the count of
other leukocyte series. Serum CRP and IgE levels
stayed almost normal. Arthritis associated AE was
confirmed by scintigraphy. Eight patients out of the
11 did not require corticosteroid treatment. Eosino-
phil count returned to normal levels within eight
weeks. All the patients had no recurrence of AE.
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